Piotr Łacina

8PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Innate immunityMedical infection agents (incl. prions)Medical biochemistry - carbohydrates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 13, 2025
Polymorphisms in Necroptosis Pathway Genes: Novel Prognostic Markers for Multiple Myeloma Treatment Outcomes.

Marcin Sokołowski, Piotr Łacina, Katarzyna Bogunia-Kubik

|Mar 14, 2025
Telomere length and telomerase reverse transcriptase gene polymorphism as potential markers of complete chimerism and GvHD development after allogeneic haematopoietic stem cell transplantation.

Marta Dratwa-Kuzmin, Piotr Lacina, Barbara Wysoczanska

|Sep 09, 2022
Polymorphisms in the Genes Coding for TLRs, NLRs and RLRs Are Associated with Clinical Parameters of Patients with Acute Myeloid Leukemia.

Katarzyna Wicherska-Pawłowska, Katarzyna Bogunia-Kubik, Bartłomiej Kuszczak

|Jun 20, 2022
Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma.

Piotr Łacina, Aleksandra Butrym, Diana Frontkiewicz

|Jan 21, 2022
BSG (CD147) Serum Level and Genetic Variants Are Associated with Overall Survival in Acute Myeloid Leukaemia.

Piotr Łacina, Aleksandra Butrym, Eliza Turlej

|Oct 25, 2021
Exploring the Extracellular Vesicle MicroRNA Expression Repertoire in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with TNF Inhibitors.

Joanna Wielińska, Rachel E Crossland, Piotr Łacina

Pageof 2

Frequent Collaborators

4 joint publications

Katarzyna Bogunia-Kubik

3 joint publications

Marta Dratwa-Kuzmin

3 joint publications

Grzegorz Mazur

2 joint publications

Aleksandra Butrym